Literature DB >> 34546401

[Severe secondary sclerosing cholangitis as manifestation of a very rare underlying disease].

Britta Franziska Zecher1,2, Roman Zenouzi1, Melanie Lang3, Panagiotis Karagiannis4, Till Clauditz5, Lutz Fischer3,6, Martina Sterneck1,3, Christoph Schramm1,2,7, Ansgar W Lohse1,2, Marcial Sebode8,9.   

Abstract

Langerhans cell histiocytosis (LCH) is a very rare cause of secondary sclerosing cholangitis. We report the case of a 42-year-old male patient with sclerosing cholangitis and histological evidence of LCH from a bile duct biopsy. Due to rapid disease progression and exhaustion of conservative therapeutic approaches the patient received a liver transplantation. Nearly 2 years after transplantation the patient has a good graft function and no signs of recurrence of the underlying LCH.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Cholangiography, endoscopic retrograde; Cholangitis, sclerosing, secondary; Histiocytosis, Langerhans cell; Liver transplantation; Unclear cholestasis

Mesh：

Year:  2021        PMID： 34546401     DOI： 10.1007/s00108-021-01148-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  10 in total

1.  Some unusual cystic lesions of the liver.

Authors:  Malte H Wehmeyer; Ansgar W Lohse; Christoph Schramm
Journal:  Gastroenterology       Date:  2013-10-29       Impact factor: 22.682

2.  Liver transplantation in an adult with sclerosing cholangitis due to multisystem Langerhans cell histiocytosis.

Authors:  R J Lee; C Leung; E J Lim; P W Angus; P S Bhathal; P Crowley; M Gonzales; D Stella; J F Seymour; A G Speer
Journal:  Am J Transplant       Date:  2011-08       Impact factor: 8.086

Review 3.  Secondary Sclerosing Cholangitis: a Review of Recent Literature.

Authors:  John Brooling; Rolando Leal
Journal:  Curr Gastroenterol Rep       Date:  2017-09

4.  Antiprogrammed Cell Death-1 Immunotherapy-Related Secondary Sclerosing Cholangitis.

Authors:  Kohei Ogawa; Kenya Kamimura; Shuji Terai
Journal:  Hepatology       Date:  2018-12-28       Impact factor: 17.425

Review 5.  Langerhans-Cell Histiocytosis.

Authors:  Carl E Allen; Miriam Merad; Kenneth L McClain
Journal:  N Engl J Med       Date:  2018-08-30       Impact factor: 91.245

Review 6.  Primary sclerosing cholangitis - a comprehensive review.

Authors:  Tom H Karlsen; Trine Folseraas; Douglas Thorburn; Mette Vesterhus
Journal:  J Hepatol       Date:  2017-08-10       Impact factor: 25.083

7.  Langerhans' cell histiocytosis of the liver in adults.

Authors:  Meya Abdallah; Thierry Généreau; Jean Donadieu; Jean-François Emile; Olivier Chazouillères; Cécile Gaujoux-Viala; Jean Cabane
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-05-06       Impact factor: 2.947

Review 8.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

Review 9.  Drug-induced cholestasis.

Authors:  Vinay Sundaram; Einar S Björnsson
Journal:  Hepatol Commun       Date:  2017-09-11

Review 10.  Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net.

Authors:  Michael Girschikofsky; Maurizio Arico; Diego Castillo; Anthony Chu; Claus Doberauer; Joachim Fichter; Julien Haroche; Gregory A Kaltsas; Polyzois Makras; Angelo V Marzano; Mathilde de Menthon; Oliver Micke; Emanuela Passoni; Heinrich M Seegenschmiedt; Abdellatif Tazi; Kenneth L McClain
Journal:  Orphanet J Rare Dis       Date:  2013-05-14       Impact factor: 4.123
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.